Activation of Nuclear Factor−κB by Tumor Necrosis Factor in Intestinal Epithelial Cells and Mouse Intestinal Epithelia Reduces Expression of the Chloride Transporter SLC26A3

Gastroenterology

Volumn 153, Issue 5, 2017, Pages 1338-1350.e3

  Kumar, Anoop ^a   Chatterjee, Ishita ^a   Gujral, Tarunmeet ^a   Alakkam, Anas ^a   Coffing, Hayley ^a   Anbazhagan, Arivarasu N ^a   Borthakur, Alip ^a   Saksena, Seema ^a,b   Gill, Ravinder K ^a   Alrefai, Waddah A ^a,b   Dudeja, Pradeep K ^a,b  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^b JESSE BROWN VA MEDICAL CENTER   (United States)

Author keywords

Intestinal Inflammation; Ion Transporter; Mouse Model; NaCl Absorption

Indexed keywords

I KAPPA B KINASE ALPHA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; PROTEIN; PROTEIN P50; SMALL INTERFERING RNA; SOLUTE CARRIER FAMILY 26 MEMBER 3 PROTEIN; SYNAPTOTAGMIN I; TUMOR NECROSIS FACTOR; UNCLASSIFIED DRUG; ANTIPORTER; BICARBONATE CHLORIDE ANTIPORTER; SLC26A3 PROTEIN, HUMAN; SLC26A3 PROTEIN, MOUSE; TNF PROTEIN, HUMAN;

ANIMAL MODEL; ARTICLE; BINDING AFFINITY; CACO-2 CELL LINE; CONTROLLED STUDY; DIARRHEA; DNA BINDING; DOWN REGULATION; GENE EXPRESSION; HT-29 CELL LINE; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; INTESTINE CRYPT; INTESTINE EPITHELIUM CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; T84 CELL LINE; ANIMAL; C57BL MOUSE; COMPLICATION; DOSE RESPONSE; DRUG EFFECTS; EPITHELIUM CELL; GENETIC TRANSFECTION; GENETICS; INFLAMMATORY BOWEL DISEASE; INTESTINE ABSORPTION; INTESTINE MUCOSA; METABOLISM; PATHOLOGY; RNA INTERFERENCE; TIME FACTOR;

ANIMALS; ANTIPORTERS; CACO-2 CELLS; CHLORIDE-BICARBONATE ANTIPORTERS; DIARRHEA; DOSE-RESPONSE RELATIONSHIP, DRUG; DOWN-REGULATION; EPITHELIAL CELLS; HT29 CELLS; HUMANS; INFLAMMATORY BOWEL DISEASES; INTESTINAL ABSORPTION; INTESTINAL MUCOSA; MICE; MICE, INBRED C57BL; NF-KAPPA B; PROMOTER REGIONS, GENETIC; RNA INTERFERENCE; TIME FACTORS; TRANSFECTION; TUMOR NECROSIS FACTOR-ALPHA;

EID: 85032735106     PISSN: 00165085     EISSN: 15280012     Source Type: Journal    
DOI: 10.1053/j.gastro.2017.08.024     Document Type: Article

References (36)

1. Priyamvada, S., Gomes, R., Gill, R.K., et al. Mechanisms underlying dysregulation of electrolyte absorption in inflammatory bowel disease−associated diarrhea. Inflamm Bowel Dis 21 (2015), 2926–2935.
2. Dudeja, P.K., Baldwin, M.L., Harig, J.M., et al. Mechanisms of Na+ transport in human distal colonic apical membrane vesicles. Biochim Biophys Acta 1193 (1994), 67–76.
3. Kato, A., Romero, M.F., Regulation of electroneutral NaCl absorption by the small intestine. Annu Rev Physiol 73 (2011), 261–281.
4. − secretion across murine duodenum. Gastroenterology 136 (2009), 893–901.
5. Makela, S., Kere, J., Holmberg, C., et al. SLC26A3 mutations in congenital chloride diarrhea. Hum Mutat 20 (2002), 425–438.
6. Schweinfest, C.W., Spyropoulos, D.D., Henderson, K.W., et al. slc26a3 (dra)-deficient mice display chloride-losing diarrhea, enhanced colonic proliferation, and distinct up-regulation of ion transporters in the colon. J Biol Chem 281 (2006), 37962–37971.
7. Gill, R.K., Borthakur, A., Hodges, K., et al. Mechanism underlying inhibition of intestinal apical Cl/OH exchange following infection with enteropathogenic E. coli. J Clin Invest 117 (2007), 428–437.
8. Borenshtein, D., Schlieper, K.A., Rickman, B.H., et al. Decreased expression of colonic Slc26a3 and carbonic anhydrase iv as a cause of fatal infectious diarrhea in mice. Infect Immun 77 (2009), 3639–3650.
9. Kuhn, R., Lohler, J., Rennick, D., et al. Interleukin-10-deficient mice develop chronic enterocolitis. Cell 75 (1993), 263–274.
10. Singh, V., Kumar, A., Raheja, G., et al. Lactobacillus acidophilus attenuates downregulation of DRA function and expression in inflammatory models. Am J Physiol Gastrointest Liver Physiol 307 (2014), G623–G631.
11. Yang, H., Jiang, W., Furth, E.E., et al. Intestinal inflammation reduces expression of DRA, a transporter responsible for congenital chloride diarrhea. Am J Physiol 275 (1998), G1445–G1453.
12. Xiao, F., Juric, M., Li, J., et al. Loss of downregulated in adenoma (DRA) impairs mucosal HCO3(−) secretion in murine ileocolonic inflammation. Inflamm Bowel Dis 18 (2012), 101–111.
13. Tak, P.P., Firestein, G.S., NF-kappaB: a key role in inflammatory diseases. J Clin Invest 107 (2001), 7–11.
14. Molodecky, N.A., Soon, I.S., Rabi, D.M., et al. Increasing incidence and prevalence of the inflammatory bowel diseases with time, based on systematic review. Gastroenterology 142 (2012), 46–54 e42 quiz e30.
15. Kumar, A., Hecht, C., Priyamvada, S., et al. Probiotic Bifidobacterium species stimulate human SLC26A3 gene function and expression in in vitro and in vivo models (abstract). Gastroenterology, 142, 2012, S542.
16. Asghar, M.N., Priyamvada, S., Nystrom, J.H., et al. Keratin 8 knockdown leads to loss of the chloride transporter DRA in the colon. Am J Physiol Gastrointest Liver Physiol 310 (2016), G1147–G1154.
17. Kumar, A., Anbazhagan, A.N., Coffing, H., et al. Lactobacillus acidophilus counteracts inhibition of NHE3 and DRA expression and alleviates diarrheal phenotype in mice infected with Citrobacter rodentium. Am J Physiol Gastrointest Liver Physiol 311 (2016), G817–G826.
18. Zhang, Y.G., Wu, S., Xia, Y., et al. Salmonella-infected crypt-derived intestinal organoid culture system for host-bacterial interactions. Physiol Rep, 2014, 2.
19. Watson, W.H., Burke, T.J., Doll, M.A., et al. S-adenosylhomocysteine inhibits NF-κB-mediated gene expression in hepatocytes and confers sensitivity to TNF cytotoxicity. Alcohol Clin Exp Res 38 (2014), 889–896.
20. Alrefai, W.A., Wen, X., Jiang, W., et al. Molecular cloning and promoter analysis of downregulated in adenoma (DRA). Am J Physiol Gastrointest Liver Physiol 293 (2007), G923–G934.
21. Saksena, S., Singla, A., Goyal, S., et al. Mechanisms of transcriptional modulation of the human anion exchanger SLC26A3 gene expression by IFN-{gamma}. Am J Physiol Gastrointest Liver Physiol 298 (2010), G159–G166.
22. Strober, W., Fuss, I.J., Proinflammatory cytokines in the pathogenesis of inflammatory bowel diseases. Gastroenterology 140 (2011), 1756–1767. e1.
23. Poritz, L.S., Garver, K.I., Tilberg, A.F., et al. Tumor necrosis factor alpha disrupts tight junction assembly. J Surg Res 116 (2004), 14–18.
24. Lukovac, S., Roeselers, G., Intestinal crypt organoids as experimental models. Verhoeckx, K., Cotter, P., López-Expósito, I., (eds.) The Impact of Food Bioactives on Health, 2015, Springer, New York, 245–253.
25. Resta-Lenert, S., Barrett, K.E., Probiotics and commensals reverse TNF-alpha- and IFN-gamma-induced dysfunction in human intestinal epithelial cells. Gastroenterology 130 (2006), 731–746.
26. Tao, Y., Drabik, K.A., Waypa, T.S., et al. Soluble factors from Lactobacillus GG activate MAPKs and induce cytoprotective heat shock proteins in intestinal epithelial cells. Am J Physiol Cell Physiol 290 (2006), C1018–C1030.
27. Clayburgh, D.R., Musch, M.W., Leitges, M., et al. Coordinated epithelial NHE3 inhibition and barrier dysfunction are required for TNF-mediated diarrhea in vivo. J Clin Invest 116 (2006), 2682–2694.
28. Xiao, F., Yu, Q., Li, J., et al. Slc26a3 deficiency is associated with loss of colonic HCO3 (-) secretion, absence of a firm mucus layer and barrier impairment in mice. Acta Physiol (Oxf) 211 (2014), 161–175.
29. Chatterjee, I., Kumar, A., Gill, R.K., et al. Mo1765 3D cell culture of CaCo2: a better model to study the functionality and regulation of intestinal ion transporters. Gastroenterology, 5, 2014, S654.
30. Amin, M.R., Orenuga, T., Tyagi, S., et al. Tumor necrosis factor-alpha represses the expression of NHE2 through NF-kappaB activation in intestinal epithelial cell model, C2BBe1. Inflamm Bowel Dis 17 (2011), 720–731.
31. Ellis, R., Goodlad, J., Limb, G., et al. Activation of nuclear factor kappa B in Crohn's disease. Inflamm Res 47 (1998), 440–445.
32. Schmid, R., Adler, G., Liptay, S., Activation of NFκB in inflammatory bowel disease. Gut, 43, 1998 586−586.
33. Ghosh, S., Hayden, M.S., New regulators of NF-κB in inflammation. Nat Rev Immunol 8 (2008), 837–848.
34. Baeuerle, P.A., Baichwal, V.R., NF-kB as a frequent target for immunosuppressive and anti-inflammatory molecules. Adv Immunol 65 (1997), 111–138.
35. Al-Sadi, R., Boivin, M., Ma, T., Mechanism of cytokine modulation of epithelial tight junction barrier. Frontiers in bioscience: a journal and virtual library, 14, 2009, 2765.
36. Hunter, M.J., Treharne, K.J., Winter, A.K., et al. Expression of wild-type CFTR suppresses NF-κB−driven inflammatory signalling. PLoS One, 5, 2010, e11598.